Revisiting the Effect of Udenafil on Exercise Performance in Patients With Fontan Circulation: Results of a Post Hoc Analysis of the FUEL Trial
David Goldberg(Fordham University), Bryan H. Goldstein(Deutsches Herzzentrum der Charité), Jon Detterich(Children's Hospital of Los Angeles), William B. Orr(Washington University in St. Louis), Michelle Ploutz(Primary Children's Hospital), Andrew S. Mackie(University of Alberta), Brian W. McCrindle(University of Toronto), Todd Nowlen(Arizona Heart Hospital), Stephen M. Paridon(Children's Hospital of Philadelphia), Anji T. Yetman(Children's Hospital & Medical Center), Ruchira Garg(Cedars-Sinai Medical Center), Marc E. Richmond(NewYork–Presbyterian Hospital), Michael V. Di Maria(Children's Hospital Colorado), Matthew D. Files(Seattle Children's Hospital), Benjamin P. Frischhertz(Vanderbilt University Medical Center), James L. Yeager(Korea Pharma (South Korea)), Daniel J. Penny(Baylor College of Medicine), Kurt R. Schumacher(University of Michigan), Kevin D. Hill(Duke University), Chenwei Hu, R. Mark Payne(Riley Hospital for Children), Jonathan B. Wagner(Children's Mercy Hospital), Anitha S. John(Children's National), Christopher K. Davis(Rady Children's Hospital-San Diego), Robert Whitehill(Emory University), Kimberly E. McHugh(Medical University of South Carolina), Salil Ginde(Children's Hospital of Wisconsin), Rahul H. Rathod(Boston Children's Hospital), Jennifer S. Yauck(Children's Hospital of Wisconsin), Mark Cartoski(DuPont (United States)), Gi Beom Kim(Seoul National University Children's Hospital), Michael G. McBride(Children's Hospital of Philadelphia), Victor Zak(Northwestern University), Gail D. Pearson(National Heart Lung and Blood Institute), Adam M. Lubert(University of Cincinnati Medical Center)
Cited by 4
Related Papers
Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease: A Scientific Statement for Health Professionals From the American Heart Association
|Circulation|2017|3.7k
Transfusion of Plasma, Platelets, and Red Blood Cells in a 1:1:1 vs a 1:1:2 Ratio and Mortality in Patients With Severe Trauma
|JAMA|2015|2.5k
Peripartum Cardiomyopathy
|JAMA|2000|860
Ischemia and No Obstructive Coronary Artery Disease (INOCA)
|Circulation|2017|745
The Agenda for Familial Hypercholesterolemia
|Circulation|2015|726